July 19, 2011 -- Shijiazhuang Yiling Pharmaceutical now expects to raise as much as 2.25 billion RMB ($348 million) in its ChiNext IPO. The latest offering price was increased by about one-third to 34.56 yuan, reflecting investor demand. Yiling, which plans to place 65 million shares, is primarily known as a TCM and nutraceutical company, though it has biological medicines in its portfolio and offers CRO services as well. More details....
